Celltrion’s Fourth-Quarter Net Profit Surges on Strong Biosimilar Sales and Affiliate Merger
Seoul: Celltrion Inc., a leading South Korean biopharmaceutical company, announced a significant increase in its fourth-quarter net profit, driven by strong sales of biosimilar drugs